Abstract
Costs of treatments by modern medicine have significantly increased causing accessibility and affordability problems. The patent protections for new drugs have killed the competition and have given the patent holder to become super rich at the cost of patients’ health. Pharmacoeconomics and outcome research have helped the government to understand the dynamics of drug price and its impact on accessibility and affordability. Outcome research is helpful in rationalizing the drug therapy and making drug therapy from product-centric to patient-centric.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmad A, Patel I, Parimilakrishnan S, Mohanta GP, Chung H, Chang J (2013) The role of pharmacoeconomics in current Indian healthcare system. J Res Pharm Pract 2(1):3–9
Committee on the Learning Health Care System in America; Institute of Medicine, Smith M, Saunders R, Stuckhardt L et al (2013) Engaging patients, families, and communities. In: Best care at lower cost: the path to continuously learning health care in America. National Academies Press, Washington
Deshpande PR, Rajan S, Sudeepthi BL, Abdul Nazir CP (2011) Patient-reported outcomes: a new era in clinical research. Perspect Clin Res 2(4):137–144
Feingold KR 2000 Cholesterol lowering drugs. Feingold KR, Anawalt B, Boyce A, et al. South Dartmouth: MDText.com, Inc
Franklin M, Lomas J, Walker S et al (2019) An educational review about using cost data for the purpose of cost-effectiveness analysis. Pharmacoeconomics 37:631–643
Halek M, Holle D, Bartholomeyczik S (2017) Development and evaluation of the content validity, practicability and feasibility of the innovative dementia-oriented assessment system for challenging behaviour in residents with dementia. BMC Health Serv Res 17:554
Hernlund E, Svedbom A, IvergĂĄrd M et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the international osteoporosis foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8(1):136. https://doi.org/10.1007/s11657-013-0136-1
Institute of Medicine (US) Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting, Adler NE, Page AEK (2008) Cancer care for the whole patient: meeting psychosocial health needs. In: The psychosocial needs of cancer patients. National Academies Press, Washington
Institute of Medicine (US) Committee on the Consequences of Uninsurance (2002) Effects of health insurance on health. In: Care without coverage: too little, too late. National Academies Press, Washington
Jo C (2014) Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol 20(4):327–337
Louie C, D'Agostino EN, Han D, Ryken TC (2019) Determining an appropriate outcome measure in neurosurgical research: investigating meaningful, valid, and practical metrics. Cureus 11(9):e5610
Robinson R (1993) Costs and cost-minimisation analysis. BMJ 307(6906):726–728
Roy V, Rana P (2018) Prescribing generics: all in a name. Indian J Med Res 147(5):442–444
Ryder HF, McDonough C, Tosteson AN, Lurie JD (2009) Decision analysis and cost-effectiveness analysis. Semin Spine Surg 21(4):216–222
Stergachis A (1995) Overview of cost-consequence modeling in outcomes research. Pharmacotherapy 15(5 Pt 2):40–42
Tunis SL (2009) A cost-effectiveness analysis to illustrate the impact of cost definitions on results, interpretations and comparability of pharmacoeconomic studies in the US. Pharmacoeconomics 27(9):735–744
Yousefi M, Assari Arani A, Sahabi B, Kazemnejad A, Fazaeli S (2014) Household health costs: direct, indirect and intangible. Iran J Public Health 43(2):202–209
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Nagappa, A.N., Bhatt, S. (2022). Introduction to Pharmacoeconomics and Outcome Research. In: Nagappa, A.N., Kanoujia, J., Bhatt, S., Naik, V. (eds) Perspectives in Pharmacy Practice. Springer, Singapore. https://doi.org/10.1007/978-981-16-9213-0_18
Download citation
DOI: https://doi.org/10.1007/978-981-16-9213-0_18
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-9212-3
Online ISBN: 978-981-16-9213-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)